Fingerprint
Dive into the research topics of 'Phase II trial of recombinant alpha-2b-Interferon and low-dose cyclophosphamide in advanced melanoma and renal cell carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II trial of recombinant alpha-2b-Interferon and low-dose cyclophosphamide in advanced melanoma and renal cell carcinoma
S. Wadler, A. I. Einzig, J. P. Dutcher, N. Ciobanu, L. Landau, P. H. Wiernik
Research output: Contribution to journal › Article › peer-review
26
Scopus
citations